METHOD OF TREATING HUMAN SYSTEMIC LUPUS ERYTHEMATOSUS
2024-05-31
专利权人SUPERHARD & NEW CARBON MATERIALS INST (SUPE-Non-standard)
申请日期2024-05-31
专利号RU2829414-C1
成果简介NOVELTY - Invention refers to medicine, namely to therapy and immunology, and can be used for treating systemic lupus erythematosus (SLE). Three consecutive procedures are performed selective plasma adsorption of DNA using a "NucleoCor" sorption column with an interval of one day with underlying drug therapy. On the next day after the third procedure, 6 methylprednisolone 500 mg intravenously is administered intravenously. USE - Medicine. ADVANTAGE - Method provides reducing the synthesis of autoantibodies by activated B-lymphocytes, normalizing the immune response, quickly achieving low activity of the disease, reducing the daily dose of prednisolone and reducing the risk of developing irreversible organ damage due to the rapid removal of pathological neutrophilic cell traps and free DNA from the bloodstream. 1 cl, 2 ex
IPC 分类号A61K-031/56 ; A61M-001/34 ; A61P-037/06
国家俄罗斯
专业领域化学化工
语种英语
成果类型专利
文献类型科技成果
条目标识符http://119.78.100.226:8889/handle/3KE4DYBR/16469
专题中国科学院新疆生态与地理研究所
作者单位
SUPERHARD & NEW CARBON MATERIALS INST (SUPE-Non-standard)
推荐引用方式
GB/T 7714
SOLOVEV S K,ASEEVA E A,NIKOLAEVA E V,et al. METHOD OF TREATING HUMAN SYSTEMIC LUPUS ERYTHEMATOSUS. RU2829414-C1[P]. 2024.
条目包含的文件
条目无相关文件。
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。